McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–99. https://doi.org/10.1161/CIR.0000000000000484.
Article
PubMed
Google Scholar
Goswami N, Marzan K, De Oliveira E, Wagner-Lees S, Szmuszkovicz J. Recurrent Kawasaki disease: a case report of three separate episodes at >4-year intervals. Children. 2018;5(11):155. https://doi.org/10.3390/children5110155.
Article
PubMed Central
Google Scholar
Guleria S, Pilania RK, Jindal AK, Bhattarai D, Suri D, Singh S. Recurrent Kawasaki disease at a tertiary care center in Chandigarh, north West India: 24 years of clinical experience. Int J Rheum Dis. 2019;22(7):1183–7. https://doi.org/10.1111/1756-185X.13519.
Article
PubMed
Google Scholar
Kaur G, Gupta J, Verma L, Passi S, Joshi M. Recurrent Kawasaki Disease Presenting to Dentists: “Think Beyond Dentition”. Int J Clin Pediatr Dent 2018;11(6):535–535. doi:https://doi.org/10.5005/jp-journals-10005-1571, Recurrent Kawasaki Disease Presenting to Dentists: “Think Beyond Dentition”.
Ulloa-Gutierrez R, Alphonse MP, Dhanranjani A, Yeung RSM. Kawasaki disease-associated cytokine storm syndrome. In: Cytokine Storm Syndrome. Springer Int Publish; 2019:393–406. doi:https://doi.org/10.1007/978-3-030-22094-5_23, Kawasaki Disease-Associated Cytokine Storm Syndrome.
Xu S, Chen M, Weng J. COVID-19 and Kawasaki disease in children. Pharmacol Res. 2020;159:104951. https://doi.org/10.1016/j.phrs.2020.104951.
Article
CAS
PubMed
PubMed Central
Google Scholar
DeBiasi RL, Song X, Delaney M, et al. Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region. J Pediatr. 2020; 223: 199–203.e1. doi:https://doi.org/10.1016/j.jpeds.2020.05.007
Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, Nguyen EL, Barsh GR, Maskatia S, Mathew R COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr Published online April 7, 2020. doi:https://doi.org/10.1542/hpeds.2020-0123, 6, 537, 540.
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771–8. https://doi.org/10.1016/S0140-6736(20)31103-X.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607–8. https://doi.org/10.1016/S0140-6736(20)31094-1.
Article
CAS
PubMed
PubMed Central
Google Scholar
Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142(5):429–36. https://doi.org/10.1161/CIRCULATIONAHA.120.048360.
Hennon TR, Penque MD, Abdul-Aziz R, Alibrahim OS, McGreevy MB, Prout AJ, et al. COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) guidelines; a Western New York approach. Prog Pediatr Cardiol. 2020;57:101232. https://doi.org/10.1016/j.ppedcard.2020.101232.
Institute of Health Economics |. Accessed January 16, 2021. https://www.ihe.ca/publications/ihe-quality-appraisal-checklist-for-case-series-studies
critical-appraisal-tools - Critical Appraisal Tools | Joanna Briggs Institute. https://joannabriggs.org/critical-appraisal-tools. Accessed 16 Jan 2021.
Matsubara T, Furukawa S, Ino T, Tsuji A, Park I, Yabuta K. A sibship with recurrent Kawasaki disease and coronary artery lesion. Acta Paediatr. 1994;83(9):1002–4. https://doi.org/10.1111/j.1651-2227.1994.tb13194.x.
Article
CAS
PubMed
Google Scholar
Nigro G, Pisano P, Krzysztoflak A. Recurrent Kawasaki disease associated with co-infection with parvovirus B19 and HIV-1 [5]. AIDS. 1993;7(2):288–90. https://doi.org/10.1097/00002030-199302000-00026.
Article
CAS
PubMed
Google Scholar
Hamada H, Sekizuka T, Oba K, Katano H, Kinumaki A, Terai M, et al. Comprehensive pathogen detection associated with four recurrent episodes of Kawasaki disease in a patient during a single year using next-generation sequencing. JMM Case Rep. 2016;3(1):e005019. https://doi.org/10.1099/jmmcr.0.005019.
Saha A, Sarkar S. Recurrent Kawasaki disease. Indian J Pediatr. 2018;85(8):693–4. https://doi.org/10.1007/s12098-017-2567-y.
Article
PubMed
Google Scholar
Verma P, Agarwal N, Maheshwari M. Recurrent Kawasaki disease. Indian Pediatr. 2015;52(2):152–4. https://doi.org/10.1097/rhu.0000000000000411.
Article
PubMed
Google Scholar
Aldemir-Kocabaş B, Kicali MM, Ramoʇlu MG, et al. Recurrent Kawasaki disease in a child with retropharyngeal involvement: A case report and literature review. Medicine (United States). 2014;93(29):e139. https://doi.org/10.1097/MD.0000000000000139.
Article
Google Scholar
Recurrent Kawasaki disease presenting as acute airway obstruction - PubMed. Accessed November 14, 2020. https://pubmed.ncbi.nlm.nih.gov/23268170/
Osman NM. Recurrent Kawasaki disease resistant to initial treatment with intravenous immunoglobulin. Sudan J Paediatr 2012;12(2):65–69. Accessed November 14, 2020. https://www.ncbi.nlm.nih.gov/pubmed/27493348.
Balasubramanian S, Ganesh R. Recurrent kawasaki disease. Indian J Pediatr. 2009;76(8):848–9. https://doi.org/10.1007/s12098-009-0157-3.
Article
CAS
PubMed
Google Scholar
Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Clinical features of patients with Kawasaki disease whose parents had the same disease. Arch Pediatr Adolesc Med. 2004;158(12):1166–9. https://doi.org/10.1001/archpedi.158.12.1166. Accessed 14 Nov 2020.
Pemberton MN, Doughty IM, Middlehurst RJ, Thornhill MH. Recurrent Kawasaki disease. Br Dent J. 1999;186(6):270–1. https://doi.org/10.1038/sj.bdj.4800085.
Article
CAS
PubMed
Google Scholar
Clinical features of recurrent Kawasaki disease in 20 children. Accessed November 14, 2020. https://www.researchgate.net/publication/23412167_Clinical_features_of_recurrent_Kawasaki_disease_in_20_children
Yang HM, Du ZD, Fu PP. Clinical features of recurrent Kawasaki disease and its risk factors. Eur J Pediatr. 2013;172(12):1641–7. https://doi.org/10.1007/s00431-013-2101-9.
Article
PubMed
Google Scholar
Lee HJ, Cho AR, Kim HS, Sohn S. Clinical Characteristics of Recurrent Kawasaki Disease. Vol 47. Korean pediatric Society; 2004.
Kang SJ, Jin BK, Hwang SJ, Kim HJ. Sequential changes in left ventricular systolic myocardial deformation mechanics in children with recurrent Kawasaki disease. J Cardiovasc Imaging. 2018;26(3):147–54. https://doi.org/10.4250/jcvi.2018.26.e12.
Article
PubMed
PubMed Central
Google Scholar
Sudo D, Nakamura Y. Nationwide surveys show that the incidence of recurrent Kawasaki disease in Japan has hardly changed over the last 30 years. Acta Paediatr Int J Paediatr. 2017;106(5):796–800. https://doi.org/10.1111/apa.13773.
Article
CAS
Google Scholar
Sudo D, Makino N, Nakamura Y. Recurrent Kawasaki disease and cardiac complications: Nationwide surveys in Japan. Arch Dis Child. 2020;105(9):848–52. https://doi.org/10.1136/archdischild-2019-317238.
Article
PubMed
Google Scholar
Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J. 2014;33(1):24–7. https://doi.org/10.1097/INF.0000000000000010.
Huang WC, Huang LM, Chang IS, et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003 2006. Pediatrics. 2009;123(3). https://doi.org/10.1542/peds.2008-2187.
Pierre R, Sue-Ho R, Watson D. Kawasaki syndrome in Jamaica. Pediatr Infect Dis J. 2000;19(6):539–43. https://doi.org/10.1097/00006454-200006000-00010.
Article
CAS
PubMed
Google Scholar
Maddox RA, Holman RC, Uehara R, Callinan LS, Guest JL, Schonberger LB, et al. Recurrent Kawasaki disease: USA and Japan. Pediatr Int. 2015;57(6):1116–20. https://doi.org/10.1111/ped.12733.
Chahal N, Somji Z, Manlhiot C, Clarizia NA, Ashley J, Yeung RSM, et al. Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada. Pediatr Int. 2012;54(3):383–7. https://doi.org/10.1111/j.1442-200X.2012.03628.x.
Falcini F, D’Adamo G, Rigante D. A four-time-recurring typical complete Kawasaki syndrome successfully treated with intravenous immunoglobulin: a case report with literature review. Rheumatol Int. 2013;33(10):2653–5. https://doi.org/10.1007/s00296-012-2485-2.
Article
PubMed
Google Scholar
Recurrent Kawasaki Disease: Mind the Age, But It Does Not Matter - PubMed. Accessed November 13, 2020. https://pubmed.ncbi.nlm.nih.gov/27219316/
Rowley AH. Multisystem inflammatory syndrome in children and Kawasaki disease: two different illnesses with overlapping clinical features. J Pediatr. 2020;224:129–32. https://doi.org/10.1016/j.jpeds.2020.06.057.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nakamura A, Ikeda K, Hamaoka K. Aetiological significance of infectious stimuli in Kawasaki disease. Front Pediatr. 2019; 7(MAY). doi:https://doi.org/10.3389/fped.2019.00244
Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis. 2005;191(4):499–502. https://doi.org/10.1086/428291.
Article
CAS
PubMed
Google Scholar
Shirato K, Imada Y, Kawase M, Nakagaki K, Matsuyama S, Taguchi F. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease. J Med Virol. 2014;86(12):2146–53. https://doi.org/10.1002/jmv.23950.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rowley AH, Baker SC, Arrollo D, Gruen LJ, Bodnar T, Innocentini N, et al. A protein epitope targeted by the antibody response to Kawasaki disease. J Infect Dis. 2020;222(1):158–68. https://doi.org/10.1093/infdis/jiaa066.
Rowley AH, Baker SC, Shulman ST, Rand KH, Tretiakova MS, Perlman EJ, et al. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease. J Infect Dis. 2011;203(7):1021–30. https://doi.org/10.1093/infdis/jiq136.
Rowley AH, Baker SC, Orenstein JM, Shulman ST. Searching for the cause of Kawasaki disease - cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol. 2008;6(5):394–401. https://doi.org/10.1038/nrmicro1853.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rowley AH, Baker SC, Shulman ST, et al. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS One. 2008;3(2). https://doi.org/10.1371/journal.pone.0001582.
Fischer P, Uttenreuther-Fischer MM, Gaedicke G. Superantigens in the aetiology of Kawasaki disease [20]. Lancet. 1996;348(9021):202. https://doi.org/10.1016/S0140-6736(05)66155-7.
Article
CAS
PubMed
Google Scholar
Li Y, Luo C, Li W, Xu Z, Zeng C, Bi S, et al. Structure-based preliminary analysis of immunity and virulence of SARS coronavirus. Viral Immunol. 2004;17(4):528–34. https://doi.org/10.1089/vim.2004.17.528.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–8. https://doi.org/10.1016/S0140-6736(20)30937-5.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259–69. https://doi.org/10.1001/jama.2020.10369.
Rapid risk assessment: Paediatric inflammatory multisystem syndrome and SARS -CoV-2 infection in children. Accessed November 16, 2020. https://www.ecdc.europa.eu/en/publications-data/paediatric-inflammatory-multisystem-syndrome-and-sars-cov-2-rapid-risk-assessment
Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. Accessed November 16, 2020. https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19
HAN Archive - 00432 | Health Alert Network (HAN). Accessed November 16, 2020. https://emergency.cdc.gov/han/2020/han00432.asp
Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. https://doi.org/10.1136/bmj.m2094.
Colomba C, La Placa S, Saporito L, et al. Intestinal involvement in Kawasaki disease. J Pediatr. 2018;202:186–93. https://doi.org/10.1016/j.jpeds.2018.06.034.
Article
PubMed
Google Scholar
Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J. 2010;29(6):483–8. https://doi.org/10.1097/INF.0b013e3181cf8705.
Article
PubMed
Google Scholar
Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25(3):239–45. https://doi.org/10.2188/jea.JE20140089.
Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao HY, et al. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis. BMJ Open. 2015;5(4):e006703. https://doi.org/10.1136/bmjopen-2014-006703.
Lee H, Kim H, Kim HS, Sohn S. NT-pro BNP : A new diagnostic screening tool for Kawasaki disease. Korean J Pediatr. 2006;49(5):539. https://doi.org/10.3345/kjp.2006.49.5.539.
Article
Google Scholar
Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS) - guidance for clinicians | RCPCH. https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance. Accessed 13 Nov 2020.